Anlong Zhu

机构：Harbin Medical University, Powerchina Huadong Engineering Corporation (China), First Affiliated Hospital of Harbin Medical University

发表论文 34 篇 · 总被引 934 次 · h-index 13

代表论文

• Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial (2021 · The Lancet Oncology · 被引 185)
• LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3 (2018 · Molecular Cancer · 被引 134)
• Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism (2020 · The Journal of Experimental Medicine · 被引 69)
• Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma (2018 · Oncology Reports · 被引 63)
• Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Randomized Phase III RELARC Trial (2024 · Journal of Clinical Oncology · 被引 47)
• Clinical implications of AEG-1 in liver metastasis of colorectal cancer (2012 · Medical Oncology · 被引 30)